Colorectal cancer is the second most common cancer in Palestine, primarily affecting males, with an incidence rate of 16.4 per 100,000. It often develops from benign polyps in the colon or rectum and is influenced by both acquired and inherited genetic mutations, with various modifiable and non-modifiable risk factors. Diagnostic methods include colonoscopy and staging is critical for determining treatment options, with a 5-year survival rate varying significantly by cancer stage.